# A Prospective, Multicenter, Post-marketing Clinical Follow-up Research to Evaluate the Long-term Safety of Ellansé-S Dermal Filler Made of PCL Microspheres for the Correction of Moderate-to-severe Nasolabial Folds

> **NCT06243315** · — · ENROLLING_BY_INVITATION · sponsor: **AQTIS Medical B.V.** · enrollment: 374 (estimated)

## Conditions studied

- Moderate-to-severe Nasolabial Folds (3-4 Level of WSRS Scores) on Both Sides of the Face

## Interventions

- **DEVICE:** Ellansé-S

## Key facts

- **NCT ID:** NCT06243315
- **Lead sponsor:** AQTIS Medical B.V.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-10-12
- **Primary completion:** 2029-09
- **Final completion:** 2029-09
- **Target enrollment:** 374 (ESTIMATED)
- **Last updated:** 2025-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06243315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06243315, "A Prospective, Multicenter, Post-marketing Clinical Follow-up Research to Evaluate the Long-term Safety of Ellansé-S Dermal Filler Made of PCL Microspheres for the Correction of Moderate-to-severe Nasolabial Folds". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06243315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*